Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial-Reference-Cited by-同舟云学术

Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial

Published:2015-04 Issue:4 Volume:169 Page:479-485
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Jaff Michael R.,Rosenfield Kenneth,Scheinert Dierk,Rocha-Singh Krishna,Benenati James,Nehler Mark,White Christopher J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects;Savji;J Am Coll Cardiol,2013

2. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis;Fowkes;Lancet,2013

3. Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication;McDermott;Circulation,2008

4. Inter-society consensus for the management of peripheral arterial disease (TASC II);Norgren;J Vasc Surg,2007

5. The growing burden of diabetes mellitus in the US elderly population;Sloan;Arch Intern Med,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes and risk factors associated with drug-coated balloon treatment for femoropopliteal artery disease in patients on maintenance hemodialysis;Heart and Vessels;2024-05-23

2. Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions;JACC: Cardiovascular Interventions;2024-05

3. Endovascular Revascularisation versus Open Surgery with Prosthetic Bypass for Femoro-Popliteal Lesions in Patients with Peripheral Arterial Disease;Journal of Clinical Medicine;2023-09-15

4. Drug-eluting, balloon-expandable, bioresorbable vascular scaffolds reduce neointimal thickness and stenosis in an animal model of percutaneous peripheral intervention;JVS-Vascular Science;2023

5. Assessment of 2-Year Mortality With Use of Drug-Coated Devices in Femoropopliteal Disease: A Real-World Experience From the Bronx, New York;Cardiovascular Revascularization Medicine;2022-08